MedPath

Microdrop administration of phenylephrine and cyclopentolate in neonates (MAPC-N)

Phase 4
Completed
Conditions
Retinopathy of prematurity
Eye - Diseases / disorders of the eye
Registration Number
ACTRN12616001266459
Lead Sponsor
niversity of Otago
Brief Summary

All infants had a successful retinopathy of prematurity eye examination following the administration of both eye drop regimens. Preliminary data analysis suggests that low dose and very low dose microdrop administration of cyclopentolate and phenylephrine is effective at dilating the neonatal pupil for retinopathy of prematurity eye examinations. Preliminary analysis of the safety data suggests no clinically or statistically significant difference in cardiovascular, respiratory or gastrointestinal effects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
16
Inclusion Criteria

All neonates that meet the Dunedin Hospital, Neonatal Intensive Care Unit (NICU) retinopathy of prematurity (ROP) screening criteria.

All infants who require pupil dilation for red reflex testing.

Exclusion Criteria

Any neonate with ROP greater than stage 2.
Any neonate with an ocular medical condition.
If the staff member who administered the eye drop was unsure if the microdrop reached the eye, then the neonate will be excluded from the trial, in accordance with the per-protocol study design.
Any neonate whom phenylephrine and/or cyclopentolate is contraindicated.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To identify whether phenylephrine 1% or 0.5% and cyclopentolate 0.2% or 0.1% in a 7 microlitre volume will achieve adequate pupil dilation (>5 mm) for retinal examination in premature neonates. Pupil dilation will be measured using two pupilometers; Colvard pupilometer and a Neuroptics pupilometer.[Pupil measurements will be taken from both eyes at baseline, 20 minute, 45 minute, 90 minute and 120 minute intervals.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath